Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer - Concepedia

Concepedia

Publication | Closed Access

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer

176

Citations

21

References

2006

Year

John Nemunaitis, Thierry Jahan, Helen J. Ross, Daniel H. Sterman, Donald Richards, Bernard A. Fox, David M. Jablons, Junko Aimi, Ann Lin, Kristen Hege

Cancer Gene Therapy

Phase 1/2Vaccine DevelopmentMedicineImmunologyAutologous TumorTherapeutic VaccinePrecision VaccinologyVaccine DesignImmunotherapyOncologyRadiation OncologyAllogeneic Gvax® VaccineLung Cancer

References

	Year	Citations

Page 1

Page 1